Home > Financial Ratios > BAFNA PHARMACEUTICALS

BAFNA PHARMACEUTICALS
Fixed Capital/Sales

    Back to All Ratios
BAFNA PHARMACEUTICALS is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for BAFNA PHARMACEUTICALS
Please provide your vote to see the results

BAFNA PHARMACEUTICALS Last 5 Year Fixed Capital/Sales History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Fixed Capital/Sales(x) 0.640.790.981.081.73

What is the latest Fixed Capital/Sales ratio of BAFNA PHARMACEUTICALS ?

The latest Fixed Capital/Sales ratio of BAFNA PHARMACEUTICALS is 0.64 based on Mar2024 Standalone results.
Year Fixed Capital/Sales
Mar20240.64
Mar20230.79
Mar20220.98
Mar20211.08
Mar20201.73

How is Fixed Capital/Sales of BAFNA PHARMACEUTICALS Trending?

Years Fixed Capital/Sales % Change
Mar2024 0.64
-18.99
Mar2023 0.79
-19.39
Mar2022 0.98
-9.26
Mar2021 1.08
-37.57
Mar2020 1.73 -

Other Financial Ratios of BAFNA PHARMACEUTICALS


Compare Fixed Capital/Sales ratio of peers of BAFNA PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS ₹208.6 Cr 2.5% 18.3% 2.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹414,533.0 Cr 3.6% 2.5% 6.2% Stock Analytics
DIVIS LABORATORIES ₹180,215.0 Cr -2.9% 1.5% 48.1% Stock Analytics
CIPLA ₹120,428.0 Cr -0.1% -2.4% -1.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹116,410.0 Cr 2.5% 4.9% 15.2% Stock Analytics
DR REDDYS LABORATORIES ₹105,253.0 Cr -0.7% -6.4% -5.2% Stock Analytics


BAFNA PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS

2.5%

18.3%

2.5%

SENSEX

-1.4%

1.8%

3.3%


You may also like the below Video Courses